LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of…
Preclinical data demonstrated POC with robust in vitro and in vivo anti-tumor activityUCART20x22 allogeneic dual CAR T has been designed…
Three poster presentations highlight the unmet need for targeted therapies in BRAF and/or NRAS-altered cancers, including non-small cell lung cancer…
YIV-906 is a botanical cancer drug Scutellaria baicalensis is one of four components of the cancer drug YIV-906 and found…
Updated Data as of December 1, 2021 from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab in Metastatic MelanomaThree-year…
This release replaces one sent out last week that had the wrong headline.There Are Reasons Neglected Tropical Diseases Shouldn't Stay…
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Stryker…
Toronto, Ontario--(Newsfile Corp. - April 8, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"),…
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended March 31, 2022 after the close of normal…
FT. MYERS, FL / ACCESSWIRE / April 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…